A PYMNTS Company

US: FTC heads to trial to stop Advocate-NorthShore hospital merger

By  |  April 10, 2016

On Monday, Advocate Health Care and NorthShore University HealthSystem will square off against the federal government in a closely watched legal fight over health care competition.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    This could appear to be an arcane battle over complicated issues such as market concentration, managed care, reimbursement rates and relevant geographic markets. But it has real-world consequences for the affordability of health care for Chicago-area consumers.

    The trial comes at a time of rapid change in health care delivery as a result of the 2010 Affordable Care Act, whose aim is to lower costs, increase access to care and improve quality by fostering competition. Hospitals are merging and buying up physician practices to achieve some of the same goals, but regulators have cast a wary eye on recent deals. If the Federal Trade Commission prevails against Advocate and NorthShore, it could slow the march toward consolidation.

    “The merger is one of the biggest hospital deals that FTC has challenged, so all eyes are on it,” said Lisl Dunlop, an antitrust lawyer at Manatt, Phelps & Phillips in New York.

    Full content: Chicago Tribune

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.